UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Switch or add-on peginterferon for chronic hepatitis B patients already on nucleos(t)ide analogue therapy (SWAP study): provisional analysis – add-on therapy superior

Journal of hepatology, 2017, Vol.66 (1), p.S60-S60

2017

Volltextzugriff (PDF)

386 HEPATITIS B RNA SPLICING SUPPORTS VIRAL REPLICATION THROUGH FUNCTIONING AS DEDICATED CORE mRNA

Journal of hepatology, 2013-04, Vol.58, p.S159-S159

2013

Volltextzugriff (PDF)

P1025 : Increasing burden of NASH/cryptogenic cirrhosis in contribution to end-stage liver complications in Asia-Pacific

Journal of hepatology, 2015-04, Vol.62, p.S732-S732

2015

Volltextzugriff (PDF)

775 VIROLOGICAL RESPONSE DOES NOT LOWER LIVER DISEASE PROGRESSION AMONG CHRONIC HEPATITIS B CIRRHOTIC PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE-ANALOGUE

Journal of hepatology, 2013-04, Vol.58, p.S316-S316

2013

Volltextzugriff (PDF)

498 DRUG INDUCED LIVER INJURY RESULTING IN ACUTE LIVER FAILURE: AN ASIAN EXPERIENCE

Journal of hepatology, 2011-03, Vol.54, p.S203-S204

2011

Volltextzugriff (PDF)

925 HUMAN FETAL LIVER PROGENITOR CELLS AND THEIR IN-VIVO DIFFERENTIATION

Journal of hepatology, 2010, Vol.52, p.S359-S359

2010

Volltextzugriff (PDF)

P661 APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S288-S289

2014

Volltextzugriff (PDF)

O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE

Journal of hepatology, 2014-04, Vol.60 (1), p.S48-S48

2014

Volltextzugriff (PDF)

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

Journal of hepatology, 2015-04, Vol.62, p.S251-S252

2015

Volltextzugriff (PDF)

188 FACTORS PREDICTING IN-HOSPITAL MORTALITY IN CIRRHOTIC PATIENTS PRESENTING WITH SEPSIS

Journal of hepatology, 2010, Vol.52, p.S81-S81

2010

Volltextzugriff (PDF)

739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)

Journal of hepatology, 2013-04, Vol.58, p.S300-S300

2013

Volltextzugriff (PDF)

Strong thermal stability of Lu3Al5O12:Ce3+ single crystal phosphor for laser lighting

Journal of luminescence, 2017-11, Vol.191, p.35-39

2017

Volltextzugriff (PDF)

Dynamic strain aging of an AISI 1025 steel coil and its relationship with macroscopic responses during the upsetting process

International journal of mechanical sciences, 2021-06, Vol.200, p.106423, Article 106423

2021

Volltextzugriff (PDF)

88 ENGINEERING VIRUS-SPECIFIC T CELL IMMUNITY TO TARGET CHRONIC HEPATITIS B VIRUS INFECTION AND HBV-RELATED HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2010, Vol.52, p.S40-S40

2010

Volltextzugriff (PDF)

561 RECONSTITUTION OF HBV SPECIFIC IMMUNITY VIA RETROVIRAL GENE TRANSFER OF A HBV CORE SPECIFIC T CELL RECEPTOR IN CHRONIC HEPATITIS B PATIENTS

Journal of hepatology, 2008, Vol.48, p.S210-S211

2008

Volltextzugriff (PDF)

[58] SUSTAINED OFF-TREATMENT HBeAg RESPONSE IN TELBIVUDINE AND LAMIVUDINE TREATED HBeAg-POSITIVE PATIENTS FROM THE GLOBE STUDY

Journal of hepatology, 2007, Vol.46, p.S27-S27

2007

Volltextzugriff (PDF)

328 HIERARCHY OF TUMOR AND VIRUS-SPECIFIC CD8 T CELL RESPONSES IN HBV-INFECTED PATIENTS WITH HEPATOCARCINOMA

Journal of hepatology, 2008, Vol.48, p.S129-S129

2008

Volltextzugriff (PDF)

HER2 inhibition in aggressive squamous cell carcinomas driven by a common MET sema domain polymorphism

Annals of oncology, 2019-10, Vol.30, p.v788

2019

Volltextzugriff (PDF)

1959P - HER2 inhibition in aggressive squamous cell carcinomas driven by a common MET sema domain polymorphism

Annals of oncology, 2019-10, Vol.30, p.v788-v788

2019

Volltextzugriff (PDF)

High power and temperature luminescence of Y3Al5O12:Ce3+ bulky and pulverized single crystal phosphors by a floating-zone method

Journal of luminescence, 2015-12, Vol.168, p.334-338

2015

Volltextzugriff (PDF)

[483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)

Journal of hepatology, 2007, Vol.46, p.S184-S184

2007

Volltextzugriff (PDF)

[407] COMPREHENSIVE ANALYSIS OF HBV GENOTYPE-SPECIFIC T CELL RESPONSE IN GENETICALLY DIFFERENT POPULATIONS PERSISTENTLY INFECTED WITH HBV GENOTYPE B OR D

Journal of hepatology, 2007, Vol.46, p.S157-S157

2007

Volltextzugriff (PDF)

Therapeutic plasma-exchange improves systemic inflammation and survival in patients with acute on chronic liver failure

Journal of hepatology, 2018-04, Vol.68, p.S45

2018

Volltextzugriff (PDF)

Novel markers predict HBs-antigen seroclearance in chronic hepatitis B patients from the SWAP clinical trial

Journal of hepatology, 2018-04, Vol.68, p.S507-S508

2018

Volltextzugriff (PDF)

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with HCV Genotype 5 or 6 Infection: The ENDURANCE-5,6 Study

Journal of hepatology, 2018-04, Vol.68, p.S39

2018

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(278)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Life Sciences & Biomedicine
(94)
Humans
(51)
Technology
(45)
Biological And Medical Sciences
(32)
Adult
(26)
Female
(26)
Physical Sciences
(24)
Microbiology
(22)
Engineering
(21)
Male
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Physics
(19)
Aged
(18)
Medical Sciences
(18)
Biochemistry & Molecular Biology
(17)
Exact Sciences And Technology
(17)
Gastroenterology And Hepatology
(17)
Middle Aged
(17)
Materials Science
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Switch or add-on peginterferon for chronic hepatitis B patients already on nucleos(t)ide analogue therapy (SWAP study): provisional analysis – add-on therapy superior

386 HEPATITIS B RNA SPLICING SUPPORTS VIRAL REPLICATION THROUGH FUNCTIONING AS DEDICATED CORE mRNA

P1025 : Increasing burden of NASH/cryptogenic cirrhosis in contribution to end-stage liver complications in Asia-Pacific

775 VIROLOGICAL RESPONSE DOES NOT LOWER LIVER DISEASE PROGRESSION AMONG CHRONIC HEPATITIS B CIRRHOTIC PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE-ANALOGUE

498 DRUG INDUCED LIVER INJURY RESULTING IN ACUTE LIVER FAILURE: AN ASIAN EXPERIENCE

925 HUMAN FETAL LIVER PROGENITOR CELLS AND THEIR IN-VIVO DIFFERENTIATION

P661 APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS

O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

188 FACTORS PREDICTING IN-HOSPITAL MORTALITY IN CIRRHOTIC PATIENTS PRESENTING WITH SEPSIS

739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)

Strong thermal stability of Lu3Al5O12:Ce3+ single crystal phosphor for laser lighting

Dynamic strain aging of an AISI 1025 steel coil and its relationship with macroscopic responses during the upsetting process

88 ENGINEERING VIRUS-SPECIFIC T CELL IMMUNITY TO TARGET CHRONIC HEPATITIS B VIRUS INFECTION AND HBV-RELATED HEPATOCELLULAR CARCINOMA

561 RECONSTITUTION OF HBV SPECIFIC IMMUNITY VIA RETROVIRAL GENE TRANSFER OF A HBV CORE SPECIFIC T CELL RECEPTOR IN CHRONIC HEPATITIS B PATIENTS

[58] SUSTAINED OFF-TREATMENT HBeAg RESPONSE IN TELBIVUDINE AND LAMIVUDINE TREATED HBeAg-POSITIVE PATIENTS FROM THE GLOBE STUDY

328 HIERARCHY OF TUMOR AND VIRUS-SPECIFIC CD8 T CELL RESPONSES IN HBV-INFECTED PATIENTS WITH HEPATOCARCINOMA

HER2 inhibition in aggressive squamous cell carcinomas driven by a common MET sema domain polymorphism

1959P - HER2 inhibition in aggressive squamous cell carcinomas driven by a common MET sema domain polymorphism

High power and temperature luminescence of Y3Al5O12:Ce3+ bulky and pulverized single crystal phosphors by a floating-zone method

[483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)

[407] COMPREHENSIVE ANALYSIS OF HBV GENOTYPE-SPECIFIC T CELL RESPONSE IN GENETICALLY DIFFERENT POPULATIONS PERSISTENTLY INFECTED WITH HBV GENOTYPE B OR D

Therapeutic plasma-exchange improves systemic inflammation and survival in patients with acute on chronic liver failure

Novel markers predict HBs-antigen seroclearance in chronic hepatitis B patients from the SWAP clinical trial

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with HCV Genotype 5 or 6 Infection: The ENDURANCE-5,6 Study

Suchergebnisse filtern